To the central content area :::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

6875 PBI
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
WANG CHIEN CHIH KAN PEI KAN PEI (02)27827561 3F.-3, No. 66, Sanchong Rd., Nangang Dist.,Taipei City 115602 , Taiwan (R.O.C.) 2024/03/26
Industry Main Business
Biotechnology and Medical Care Pharmosa Biopharm Inc.(PBI) is a world-class biotechnology company focusing on developing a new drug by exploiting our proprietary formulation and manufacturing technology. With regional/global strategic partnerships,we commercialize our product through 505(b)2 or hybrid applications to regulatory authorities. Our Vision: We strive for excellence in order to improve quality of life for people through innovation and sustained quality. Our Mission: We expand the potential of existing drugs by exploiting innovative delivery formulations and medical devices,then bringing the combined medicines to patients and healthcare providers.
Market Information ( 2024/05/30 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
273.316 79.00  75.80  76.50  -0.20  427 N/A N/A
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N N N Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.